# Norstella: At Norstella, our mission is simple: to help patients gain access to life\-saving therapies\. > Norstella is a group of market\-leading pharmaceutical solutions providers that help clients navigate complexities at each step of the drug development life cycle, from pipeline to patient\. Generated by Yoast SEO v27.7, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Home](https://www.norstella.com/) - [ Meet Norstella at ISPE](https://www.norstella.com/meet-norstella-at-ispe-2026/) - [Real\-World Data After Dark](https://www.norstella.com/real-world-data-after-dark/) - [Trigger Alerts](https://www.norstella.com/trigger-alerts/) - [RWD Insights](https://www.norstella.com/rwd-insights/) ## Floating Elements - [White Paper: Closing the Strategy Gap](https://www.norstella.com/e-floating-buttons/white-paper-closing-the-strategy-gap/) ## Employee Spotlights - [Claire Riches](https://www.norstella.com/employee_spotlight/claire-riches/) - [Allison Perry](https://www.norstella.com/employee_spotlight/allison-perry/) - [Nicole Shalit](https://www.norstella.com/employee_spotlight/nicole-shalit/) - [Tracey Barry](https://www.norstella.com/employee_spotlight/tracey-barry/) - [Maxine Finding](https://www.norstella.com/employee_spotlight/maxine-finding/) ## Events - [Ai4](https://www.norstella.com/events/ai4/): This must\-attend event provides you with dedicated opportunities to network with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers\. - [ISPOR EU](https://www.norstella.com/events/ispor-eu/): This must\-attend event provides you with dedicated opportunities to network with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers\. - [AMCP Nexus](https://www.norstella.com/events/amcp-nexus/): AMCP Nexus attracts more than 3,000 member and non\-member managed care decision\-makers\. Attendees include individuals from health plans, PBMs, biopharmaceutical companies, consultants, and other leaders working within managed care pharmacy\.  Enjoy education sessions, attend industry workshops, and experience the Expo where exhibitors will showcase the latest innovations and newest products\. - [Fierce Pharma Week](https://www.norstella.com/events/fierce-pharma-week/): Fierce Pharma Week brings together four communities: Pharma Marketing, PR \& Communications, Commercialization, and Medical Affairs\. Through thought leadership, networking and new connections, communities can share common and unique challenges faced by their counterparts to better support each other\. - [ISPE](https://www.norstella.com/events/ispe/): This conference brings together more than 1,500 leaders representing industry, service providers, government/regulatory agencies, academia, consultants and students from many countries \- all dedicated to advancing the health of the public\. ## Experts - [Ilan Behm](https://www.norstella.com/experts/ilan-behm/) - [Allison Perry, PhD](https://www.norstella.com/experts/allison-perry/) - [Becky Hollenberg, MPH](https://www.norstella.com/experts/becky-hollenberg/) - [Meghana Shamsunder, PhD, MPH](https://www.norstella.com/experts/meghana-shamsunder/) - [Mike Munsell, PhD](https://www.norstella.com/experts/mike-munsell/) ## In the News - [Norstella’s AI bet: Clinical trials are often won or lost before the first patient enrolls](https://www.norstella.com/in-the-news/ai-bet-clinical-trials-often-won-lost-before-first-patient-enrolls/) ## Insights - [The Hidden Obesity Population: Why Diagnosis Codes Fail Pharma, Payers, and Patients](https://www.norstella.com/insight/the-hidden-obesity-population-why-diagnosis-codes-fail-pharma-payers-and-patients/) - [Breaking down the top three barriers to patient access](https://www.norstella.com/insight/breaking-down-top-three-barriers-patient-access/) - [What the changing definition of patient access means for pharma manufacturers](https://www.norstella.com/insight/what-changing-definition-patient-access-means-pharma-manufacturers/) - [Norstella SMEs reflect on the biggest stories of 2022 and the industry trends to come](https://www.norstella.com/insight/norstella-smes-reflect-biggest-stories-2022-industry-trends-come/) - [Improving market access: Are you making the most of real\-world data?](https://www.norstella.com/insight/improving-market-access-making-most-real-world-data/) ## Press Releases - [Norstella Launches Atlas, an Agentic AI Platform Built on Biopharma's Most Connected Data](https://www.norstella.com/press-releases/launches-atlas-agentic-ai-platform-built-biopharmas-most-connected-data/): New York – July 28, 2026: Norstella, the leading global provider of pharma intelligence solutions, today announced the launch of the Pipeline\-to\-Patient Productivity Index \(P3i\), a new annual benchmark measuring R\&D productivity, market access, and commercial return across the top 25 global biopharma companies\. - [Norstella Launches Pipeline\-to\-Patient Productivity Index to Benchmark Biopharma Performance Across the Drug Development Lifecycle](https://www.norstella.com/press-releases/launches-pipeline-patient-productivity-index/): New York – July 28, 2026: Norstella, the leading global provider of pharma intelligence solutions, today announced the launch of the Pipeline\-to\-Patient Productivity Index \(P3i\), a new annual benchmark measuring R\&D productivity, market access, and commercial return across the top 25 global biopharma companies\. - [Evaluate Recognized for Artificial Intelligence Innovation in 9th Annual AI Breakthrough Awards Program](https://www.norstella.com/press-releases/evaluate-pharma-ai-award-2026/): LONDON, June 25, 2026 – Evaluate, a Norstella company and the leading global provider of market insights for the pharmaceutical industry, today announced that Ask Ella has been named “Enterprise AI Search Solution of the Year” in the 9th annual AI Breakthrough Awards program\. - [Panalgo introduces IHD Cloud, a transformative solution for RWE data and analytics centralization](https://www.norstella.com/press-releases/panalgo-introduces-ihd-cloud/): Boston, MA \- Sept\. 5, 2024 \- Panalgo, a Norstella company committed to revolutionizing healthcare data analytics, is announcing the launch of IHD Cloud, a cutting\-edge solution that will transform how organizations manage and use real\-world data \(RWD\) to generate real\-world evidence \(RWE\)\. Powered by Amazon Web Services \(AWS\), IHD Cloud offers a scalable and flexible platform to centralize data and technology, driving meaningful and timely insights for any evidence generating organization\. - [Norstella introduces NorstellaLinQ, the biopharma industry’s first fully integrated data asset](https://www.norstella.com/press-releases/norstella-introduces-norstellalinq/): NEW YORK – October 8, 2024 \- Today, Norstella unveiled NorstellaLinQ, the biopharma industry’s first and only fully integrated data asset combining both real\-world data \(RWD\) — including open and closed claims, lab results and structured and unstructured electronic medical records \(EMR\) — with Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data\. ## Resources - [Addressing Cost Barriers and Enhancing Medicare Access Strategies to Improve Commercialization Strategy](https://www.norstella.com/resource/addressing-cost-barriers-enhancing-medicare-access-strategies-improve-commercialization-strategy/) - [Unlocking Value Potential for a Client’s Rare Disease Treatment](https://www.norstella.com/resource/unlocking-value-potential-clients-rare-disease-treatment/) - [Complex Cohort Identification Fuels Real\-Time HCP Targeting](https://www.norstella.com/resource/complex-cohort-identification-fuels-real-time-hcp-targeting/) - [Powering Unbiased Outcomes Research with Longitudinal Data](https://www.norstella.com/resource/powering-unbiased-outcomes-research-longitudinal-data/) - [Unstructured EHR Data Expands Cohort Identification by 1,500%](https://www.norstella.com/resource/unstructured-ehr-data-expands/) ## Categories - [Case study](https://www.norstella.com/category/case-study/) - [Infographic](https://www.norstella.com/category/infographic/) - [Video](https://www.norstella.com/category/video/) - [Press Releases](https://www.norstella.com/category/press-releases/) - [Article](https://www.norstella.com/category/article/) ## Tags - [NorstellaLinQ](https://www.norstella.com/tag/norstellalinq/) ## Publication Therapeutic Areas - [Metabolic \& Endocrine](https://www.norstella.com/publication-therapeutic-areas/metabolic-endocrine/) - [Renal \& Urology](https://www.norstella.com/publication-therapeutic-areas/renal-urology/) ## Publication Topics - [Type 1 Diabetes](https://www.norstella.com/publication-topics/type-1-diabetes/) - [IgA Nephropathy](https://www.norstella.com/publication-topics/iga-nephropathy/) ## Publication Types - [Conference Poster / Abstract](https://www.norstella.com/publication-types/conference-poster-abstract/) - [Peer\-Reviewed](https://www.norstella.com/publication-types/peer-reviewed/) ## Optional - [Sitemap index](https://www.norstella.com/sitemap_index.xml)